World Drug Safety Congress Americas 2019 is organized by Terrapinn Ltd and will be held from Apr 15 - 17, 2019 at Pennsylvania Convention Center, Philadelphia, Pennsylvania, United States of America.
For over 10 years, The World Drug Safety Congress Americas has served as the only commercially focused event for the pharmacovigilance community.
In 2019, Proud to be the only event to gather over 50 Global Heads of Safety and Pharmacovigilance, as well as 150+ other speakers from the leading pharmaceutical companies and emerging biotechs.
The discussions will center on the advancement of next-generation technology and the data that has contributed to automating and improving PV methodologies, resulting in improved safety for patients. As expand the discussions further, the 2019 edition will be featuring a predictive safety track with hundreds of toxicology, non-clinical safety executives discussing toxicity measurement & data, translational safety, predictive models and trial design. In addition to that, new medical device program will bring into perspective pharmacovigilance and safety approaches in apps, diagnostics, and combination products.
Global Pharmacovigilance track will help the industry assess the challenges and opportunities of setting a PV operation abroad, with perspectives from pharma and regulatory authorities from around the world.
These are the 6 topic areas in the 2019 program:
Through a focus on risk assessment, the Heads of Safety and PV will debate and brainstorm about the needed organizational structure, technology infrastructure, regulatory approach, and ways to improve post-market authorization, risk in the drug development life-cycle and pharmacoepidemiology.
Next Gen Tech & Data:
Innovation in technology, data, evidence, artificial intelligence, and machine learning are the key areas explored by the industry in our program as they promote approaches in data collection methods, signal detection, automation, adoption, and implementation.
From a value assessment to regulatory harmonization, the Global PV focus of our program will address the approached to the internationalization of pharmacovigilance approaches as the industry penetrates new markets for medicines and medical devices.
Bringing together toxicology, translational data, trial design, and model selection to help your company increase the accuracy of safety predictions.
No other conference addresses the evolving landscape of safety for medical devices from a practical and innovative perspective. This bold focus of our program will bring pharma, biotechs, medical device developers and regulatory agencies to discuss the need for modern regulation that meets patient safety needs.
By shifting “patient centricity” from rhetoric into practical applications, the industry will examine patient management and patient safety profiles and analyze their effects on safety with a focus on improving the patient experience as a whole.
Registration Fee for Group Bookings :
• 3 Day Pass - (Conference + Workshop Day) - Group Booking - USD $615 Book a group of 3+ before 08 February 2019
saving USD $260 per person
• 2 Day Pass - Group Booking - USD $490 Book a group of 3+ before 08 February 2019
saving USD $210 per person
Additional details will be posted as soon as they are available.
|Contact No. :||+1 212 379 6322
+1 646 619 1774
|Registration Type||End Date||Price|
|2 Day Individual Pass - Early Fee||08 Feb,2019||USD 700.00|
|2 Day Individual Pass - Regular Fee||14 Apr,2019||USD 1000.00|
|3 Day Pass (Conference + Workshop Day) - Individual Pass - Early Fee||08 Feb,2019||USD 875.00|
|3 Day Pass (Conference + Workshop Day) - Individual Pass - Regular Fee||14 Apr,2019||USD 1250.00|